A large cell neuroendocrine carcinoma (LCNEC) of the thymus is a very rare malignant tumor that has a very poor prognosis. The detailed clinical features of LCNEC are still unknown, including the long term prognoses and the definitive modalities of the treatment for LCNEC of the thymus. We are reporting 2 cases of an enlarged LCNEC of the thymus, both of which were diagnosed and treated by surgical resection followed by postoperative adjuvant chemoradiation therapy. Although recurrences and metastases of the LCNEC were noticed 1 and 4 years postoperatively for each case, aggressive surgical resection and adjuvant chemoradiation therapy may be helpful for a patient's long term survival.
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CASE REPORT

1) Case 1
A 64-year-old male patient was admitted due to a 1 month history of cough prior to admission. He had been relatively healthy except for hypertension for 10 years. He had smoked one pack of cigarettes every day for 30 years, but he had stopped smoking 5 years prior to admittance. A physical examination revealed no specific findings. All laboratory results were within the normal limits including carcinoembryonic antigen (CEA) levels. The chest posteroanterior (PA) radiograph (Fig. 1A) showed a large spherical mass obscuring the right heart border. A chest computed tomography (CT) ( 
2) Case 2
A 57-year-old male patient was admitted due to a known mediastinal mass that had been discovered by coronary computed tomography 6 months before this admission for the evaluation of exertional chest pain. He had been hypertensive for 5 years and received a left parotidectomy due to Warthin's tumor 5 years before admission. He was a 30-pack/year smoker, but he quit smoking 3 years prior to admittance. His physical examination was normal. His CEA level was normal.
His chest PA (Fig. 3A) shows a bilateral lobulated large mediastinal mass. His chest CT (Fig. 3B) the best chance for a definitive diagnosis and treatment for thymic tumors [5] . We were able to make a final definitive diagnosis of LCNEC of the thymus and confirmed Masaoka stage IVB by thoracotomies in our two cases. There is still no single series or institute of study for these tumors. We were able to find several case reports [3, [5] [6] [7] [8] [3, 5, 6] . Cardillo et al. [3] reported that the 10-year survival rate was 100% in typical carcinoid patients but 0%
in LCNEC patients. However, Ogawa et al. [7] with Cisplatin and Irinotecan. Dutta et al. [8] reported a case of LCNEC with sternal invasion. These two case studies reported a complete en bloc resection with postoperative chemoradiation therapy, which may be beneficial for long-term survival and to prevent local recurrence and distant metastasis [7, 8] . To obtain a definite diagnosis and to remove the masses putting pressure on the mediastinum, we had performed radical resection, although incomplete, for our two cases, plus a preoperative chemotherapy procedure in the second case, hoping for a reduction in the tumor size with postoperative chemoradiation. The two patients have been alive for four years and one year to the present day, although they have local recurrences and distant metastases. We believe that the aggressive therapy described in this report may be helpful for improving the quality of life, delaying local recurrence, and increasing survival.
